期刊文献+

谷胺酰胺颗粒灌肠对溃疡性结肠炎患者IFN-γ、IL-4、IL-8的影响及疗效观察 被引量:13

Effect of glutamine granules enema on IFN-γ,IL-4,IL-8 in patients with ulcerative colitis and observation of clinical efficacy
原文传递
导出
摘要 目的探讨谷胺酰胺颗粒灌肠对溃疡性结肠炎患者IFN-γ、IL-4、IL-8的影响及疗效观察。方法 80例溃疡性结肠炎患者随机分为观察组和对照组各40例,观察组给予谷胺酰胺颗粒灌肠,对照组给予柳氮磺胺吡啶保留灌肠,疗程4周,观察比较2组的疗效及IFN-γ、IL-4、IL-8的变化。结果经过4周的治疗,治疗组的总有效率为95.0%,对照组的总有效率为70.0%,2组总有效率比较差异有统计学意义(P<0.05);2组患者治疗前IFN-γ、IL-4、IL-8分别比较,差异无统计学意义;治疗4周后,IFN-γ、IL-8均明显降低,且治疗组与对照组比较,差异有统计学意义(P<0.05);治疗4周后,IL-4的表达水平较治疗前明显增加,差异有统计学意义(P<0.05);2组间比较,差异有统计学意义(P<0.05)。结论谷胺酰胺颗粒灌肠治疗溃疡性结肠炎,能降低血清细胞因子IFN-γ、IL-4、IL-8,可能参与UC的发病机制之一。 OBJECTIVE To investigate the effects and efficacy of glutamine granules enema on ulcerative colitis patients with IFN-γ,IL-4,IL-8. METHODS A total of 80 patients with ulcerative colitis were randomly divided into two groups and the control group 40 cases observed were given glutamine granules enema,the control group received sulfasalazine enema for 4 weeks,cases were evaluated and observed IFN-γ,IL-4,IL-8 changes. RESULTS After 4 weeks of treatment,the total effective rate of the treatment group,was 95.0% but in the control group the total effective rate was 70.0%,total effective difference between the two groups was significant(P〈0.05).Two groups of patients before IFN-γ,IL-4,IL-8,respectively,the difference was not significant;After 4 weeks,IFN-γ,IL-8 were significantly reduced,and the treatment group and control group,the difference was statistically significant.After 4 weeks of treatment,IL-4 expression levels increased significantly compared with before treatment,the difference was significant.Between the two groups,the difference was significant. CONCLUSION Ulcerative colitis enema treated by glutamine granules can reduce serum cytokines IFN-γ,IL-4,IL-8,which may be involved in the pathogenesis of UC.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2011年第22期4742-4744,共3页 Chinese Journal of Nosocomiology
关键词 溃疡性结肠炎 保留灌肠 谷胺酰胺颗粒 IFN-Γ IL-4 IL-8 Ulcerative colitis Retention enema Glutamine granules IFN-γ IL-4 IL-8
  • 相关文献

参考文献4

二级参考文献23

  • 1Bao-Ping Wu~1 Bing Xiao~1 Tian-Mo Wan~1 Ya-Li Zhang~1 Zhen-Shu Zhang~1 Dian-Yuan Zhou~1 Zhuo-Sheng Lai~1 Chun-Fang Gao~2 1 Institute for Digestive Diseases,Nanfang Hospital,Guangzhou 510515,Guangdong Province,China2 Surgical Department of Colon and Rectum,150 Central Hospital,Luoyang 471031,Henan Province,China.Construction and selection of the natural immune Fab antibody phage display library from patients with colorectal cancer[J].World Journal of Gastroenterology,2001,7(6):811-815. 被引量:9
  • 2中国炎症性肠病协作组,王玉芳,欧阳钦.3100例溃疡性结肠炎住院病例回顾分析[J].中华消化杂志,2006,26(6):368-372. 被引量:267
  • 3姚文柱.炎症性肠病的免疫调节剂治疗[J].国外医学(内科学分册),1996,23(12):510-512. 被引量:9
  • 4蒋维国,徐华.溃疡性结肠炎患者外周血T淋巴细胞亚群检测及其意义[J].中国肛肠病杂志,1997,17(1):6-7. 被引量:17
  • 5Danese S, Sans M, Fiocchi C. Inflammatory bowel disease: the role of environmental factors[J]. Autoimmunity Rev, 2004, 3(5): 390-400.
  • 6Kombluth A, Sachar DB, Practice Para meters Committee of the American Col- lege of Gastroenterology. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee[J]. Am J Gastroenterol 2004, 99(2): 1371-1385.
  • 7TRUELOVE SC,WITTS LJ.Cortisone in ulcerative colitis; final report on a therapeutic trial[J].Br Med J,1955,2 (4947):1041.
  • 8DAPERNO M.SOSTEGNI R,ROCCA R,et al.Review article:medical treatment of severe ulcerative colitis[J].Aliment Pharmacol Ther,2002,16 (Suppl.4):7.
  • 9KORNBLUTH A,SACHAR DB.Ulcerative Colitis Practice Guidelines in Adults (Update):American College of Gastroenterology,Practice Parameters Committee[J].The American Journal of Gastroenterology,2004,99 (7):1371.
  • 10RIZZELLO F,GIONCHETTI P,GALEAZZI R,et al.Oral beclomethasone dipropionate in patients with mild to moderate ulcerative colitis:a dose-finding study[J].Adv Ther,2001,18(6):261.

共引文献1146

同被引文献136

引证文献13

二级引证文献125

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部